User menu

Alzheimer’s Disease Biomarkers and Future Decline in Cognitive Normal Older Adults

Bibliographic reference Dumurgier, Julien ; Hanseeuw, Bernard J. ; Hatling, Frances B. ; Judge, Kelly A. ; Schultz, Aaron P. ; et. al. Alzheimer’s Disease Biomarkers and Future Decline in Cognitive Normal Older Adults. In: Journal of Alzheimer's Disease, Vol. 60, p. 1451-1459 (2017)
Permanent URL http://hdl.handle.net/2078.1/190003
  1. Prince Martin, Bryce Renata, Albanese Emiliano, Wimo Anders, Ribeiro Wagner, Ferri Cleusa P., The global prevalence of dementia: A systematic review and metaanalysis, 10.1016/j.jalz.2012.11.007
  2. Bateman Randall J., Xiong Chengjie, Benzinger Tammie L.S., Fagan Anne M., Goate Alison, Fox Nick C., Marcus Daniel S., Cairns Nigel J., Xie Xianyun, Blazey Tyler M., Holtzman David M., Santacruz Anna, Buckles Virginia, Oliver Angela, Moulder Krista, Aisen Paul S., Ghetti Bernardino, Klunk William E., McDade Eric, Martins Ralph N., Masters Colin L., Mayeux Richard, Ringman John M., Rossor Martin N., Schofield Peter R., Sperling Reisa A., Salloway Stephen, Morris John C., Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease, 10.1056/nejmoa1202753
  3. Rajan Kumar B., Wilson Robert S., Weuve Jennifer, Barnes Lisa L., Evans Denis A., Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia, 10.1212/wnl.0000000000001774
  4. Petersen Ronald, Early Diagnosis of Alzheimers Disease: Is MCI Too Late?, 10.2174/156720509788929237
  5. Cummings J. L., Doody R., Clark C., Disease-modifying therapies for Alzheimer disease: Challenges to early intervention, 10.1212/01.wnl.0000295996.54210.69
  6. Sperling R. A., Jack C. R., Aisen P. S., Testing the Right Target and Right Drug at the Right Stage, 10.1126/scitranslmed.3002609
  7. Blennow Kaj, Hampel Harald, Weiner Michael, Zetterberg Henrik, Cerebrospinal fluid and plasma biomarkers in Alzheimer disease, 10.1038/nrneurol.2010.4
  8. Herholz Karl, Ebmeier Klaus, Clinical amyloid imaging in Alzheimer's disease, 10.1016/s1474-4422(11)70123-5
  9. Olsson Bob, Lautner Ronald, Andreasson Ulf, Öhrfelt Annika, Portelius Erik, Bjerke Maria, Hölttä Mikko, Rosén Christoffer, Olsson Caroline, Strobel Gabrielle, Wu Elizabeth, Dakin Kelly, Petzold Max, Blennow Kaj, Zetterberg Henrik, CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis, 10.1016/s1474-4422(16)00070-3
  10. Knopman D. S., Diagnostic tests for Alzheimer disease: FDG-PET imaging is a player in search of a role, 10.1212/cpj.0b013e31825a7801
  11. Jack Clifford R., Barkhof Frederik, Bernstein Matt A., Cantillon Marc, Cole Patricia E., DeCarli Charles, Dubois Bruno, Duchesne Simon, Fox Nick C., Frisoni Giovanni B., Hampel Harald, Hill Derek L.G., Johnson Keith, Mangin Jean-François, Scheltens Philip, Schwarz Adam J., Sperling Reisa, Suhy Joyce, Thompson Paul M., Weiner Michael, Foster Norman L., Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer’s disease, 10.1016/j.jalz.2011.04.007
  12. Burnham Samantha C, Bourgeat Pierrick, Doré Vincent, Savage Greg, Brown Belinda, Laws Simon, Maruff Paul, Salvado Olivier, Ames David, Martins Ralph N, Masters Colin L, Rowe Christopher C, Villemagne Victor L, Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study, 10.1016/s1474-4422(16)30125-9
  13. Fagan Anne M., Head Denise, Shah Aarti R., Marcus Daniel, Mintun Mark, Morris John C., Holtzman David M., Decreased cerebrospinal fluid Aβ42correlates with brain atrophy in cognitively normal elderly, 10.1002/ana.21559
  14. Lowe V. J., Weigand S. D., Senjem M. L., Vemuri P., Jordan L., Kantarci K., Boeve B., Jack C. R., Knopman D., Petersen R. C., Association of hypometabolism and amyloid levels in aging, normal subjects, 10.1212/wnl.0000000000000467
  15. Nettiksimmons J., Harvey D., Brewer J., Carmichael O., DeCarli C., Jack C.R., Petersen R., Shaw L.M., Trojanowski J.Q., Weiner M.W., Beckett L., Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline, 10.1016/j.neurobiolaging.2010.04.025
  16. Pankratz V. S., Roberts R. O., Mielke M. M., Knopman D. S., Jack C. R., Geda Y. E., Rocca W. A., Petersen R. C., Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging, 10.1212/wnl.0000000000001437
  17. Stomrud Erik, Hansson Oskar, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Londos Elisabet, Correlation of Longitudinal Cerebrospinal Fluid Biomarkers With Cognitive Decline in Healthy Older Adults, 10.1001/archneurol.2009.316
  18. Sutphen Courtney L., Jasielec Mateusz S., Shah Aarti R., Macy Elizabeth M., Xiong Chengjie, Vlassenko Andrei G., Benzinger Tammie L. S., Stoops Erik E. J., Vanderstichele Hugo M. J., Brix Britta, Darby Heather D., Vandijck Manu L. J., Ladenson Jack H., Morris John C., Holtzman David M., Fagan Anne M., Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age, 10.1001/jamaneurol.2015.1285
  19. Vemuri P., Wiste H. J., Weigand S. D., Shaw L. M., Trojanowski J. Q., Weiner M. W., Knopman D. S., Petersen R. C., Jack C. R., , MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change, 10.1212/wnl.0b013e3181af79fb
  20. Dagley Alexander, LaPoint Molly, Huijbers Willem, Hedden Trey, McLaren Donald G., Chatwal Jasmeer P., Papp Kathryn V., Amariglio Rebecca E., Blacker Deborah, Rentz Dorene M., Johnson Keith A., Sperling Reisa A., Schultz Aaron P., Harvard Aging Brain Study: Dataset and accessibility, 10.1016/j.neuroimage.2015.03.069
  21. Hughes C. P., Berg L., Danziger W. L., Coben L. A., Martin R. L., A new clinical scale for the staging of dementia, 10.1192/bjp.140.6.566
  22. Morris John C., Weintraub Sandra, Chui Helena C., Cummings Jeffrey, DeCarli Charles, Ferris Steven, Foster Norman L., Galasko Douglas, Graff-Radford Neill, Peskind Elaine R., Beekly Duane, Ramos Erin M., Kukull Walter A., The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers : , 10.1097/01.wad.0000213865.09806.92
  23. Morris J. C., The Clinical Dementia Rating (CDR): Current version and scoring rules, 10.1212/wnl.43.11.2412-a
  24. Hanseeuw Bernard J., Schultz Aaron P., Betensky Rebecca A., Sperling Reisa A., Johnson Keith A., Decreased hippocampal metabolism in high-amyloid mild cognitive impairment, 10.1016/j.jalz.2016.06.2357
  25. Johnson Keith A., Gregas Matt, Becker John A., Kinnecom Catherine, Salat David H., Moran Erin K., Smith Erin E., Rosand Jonathan, Rentz Dorene M., Klunk William E., Mathis Chester A., Price Julie C., DeKosky Steven T., Fischman Alan J., Greenberg Steven M., Imaging of amyloid burden and distribution in cerebral amyloid angiopathy, 10.1002/ana.21164
  26. Mormino E. C., Betensky R. A., Hedden T., Schultz A. P., Ward A., Huijbers W., Rentz D. M., Johnson K. A., Sperling R. A., , Amyloid and APOE  4 interact to influence short-term decline in preclinical Alzheimer disease, 10.1212/wnl.0000000000000431
  27. Gustafson D. R, Skoog I., Rosengren L., Zetterberg H., Blennow K., Cerebrospinal fluid  -amyloid 1-42 concentration may predict cognitive decline in older women, 10.1136/jnnp.2006.100529
  28. Skoog I., Davidsson P., Aevarsson Ó., Vanderstichele H., Vanmechelen E., Blennow K., Cerebrospinal Fluid Beta-Amyloid 42 Is Reduced before the Onset of Sporadic Dementia: A Population-Based Study in 85-Year-Olds, 10.1159/000068478
  29. Stomrud Erik, Hansson Oskar, Blennow Kaj, Minthon Lennart, Londos Elisabet, Cerebrospinal Fluid Biomarkers Predict Decline in Subjective Cognitive Function over 3 Years in Healthy Elderly, 10.1159/000105017
  30. Roe C. M., Fagan A. M., Grant E. A., Hassenstab J., Moulder K. L., Maue Dreyfus D., Sutphen C. L., Benzinger T. L. S., Mintun M. A., Holtzman D. M., Morris J. C., Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later, 10.1212/wnl.0b013e3182918ca6
  31. Fagan Anne M., Roe Catherine M., Xiong Chengjie, Mintun Mark A., Morris John C., Holtzman David M., Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults, 10.1001/archneur.64.3.noc60123
  32. Glodzik Lidia, de Santi Susan, Tsui Wai Hon, Mosconi Lisa, Zinkowski Raymond, Pirraglia Elizabeth, Wang Hui Yu, Li Yi, Rich Kenneth E., Zetterberg Henrik, Blennow Kaj, Mehta Pankaj, de Leon Mony J., Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders, 10.1016/j.neurobiolaging.2009.12.026
  33. Palmqvist Sebastian, Zetterberg Henrik, Blennow Kaj, Vestberg Susanna, Andreasson Ulf, Brooks David J., Owenius Rikard, Hägerström Douglas, Wollmer Per, Minthon Lennart, Hansson Oskar, Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42 : A Cross-Validation Study Against Amyloid Positron Emission Tomography, 10.1001/jamaneurol.2014.1358
  34. Palmqvist Sebastian, Zetterberg Henrik, Mattsson Niklas, Johansson Per, Minthon Lennart, Blennow Kaj, Olsson Mattias, Hansson Oskar, , , Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease, 10.1212/wnl.0000000000001991
  35. Donohue Michael C., Sperling Reisa A., Petersen Ronald, Sun Chung-Kai, Weiner Michael W., Aisen Paul S., , Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons, 10.1001/jama.2017.6669
  36. Toledo Jon B, , Weiner Michael W, Wolk David A, Da Xiao, Chen Kewei, Arnold Steven E, Jagust William, Jack Clifford, Reiman Eric M, Davatzikos Christos, Shaw Leslie M, Trojanowski John Q, Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition, 10.1186/2051-5960-2-26
  37. Soldan Anja, Pettigrew Corinne, Cai Qing, Wang Mei-Cheng, Moghekar Abhay R., O’Brien Richard J., Selnes Ola A., Albert Marilyn S., , Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change, 10.1001/jamaneurol.2016.0194
  38. Benzinger T. L. S., Blazey T., Jack C. R., Koeppe R. A., Su Y., Xiong C., Raichle M. E., Snyder A. Z., Ances B. M., Bateman R. J., Cairns N. J., Fagan A. M., Goate A., Marcus D. S., Aisen P. S., Christensen J. J., Ercole L., Hornbeck R. C., Farrar A. M., Aldea P., Jasielec M. S., Owen C. J., Xie X., Mayeux R., Brickman A., McDade E., Klunk W., Mathis C. A., Ringman J., Thompson P. M., Ghetti B., Saykin A. J., Sperling R. A., Johnson K. A., Salloway S., Correia S., Schofield P. R., Masters C. L., Rowe C., Villemagne V. L., Martins R., Ourselin S., Rossor M. N., Fox N. C., Cash D. M., Weiner M. W., Holtzman D. M., Buckles V. D., Moulder K., Morris J. C., Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease, 10.1073/pnas.1317918110
  39. Morbelli S., Perneczky R., Drzezga A., Frisoni G. B., Caroli A., van Berckel B. N. M., Ossenkoppele R., Guedj E., Didic M., Brugnolo A., Naseri M., Sambuceti G., Pagani M., Nobili F., Metabolic Networks Underlying Cognitive Reserve in Prodromal Alzheimer Disease: A European Alzheimer Disease Consortium Project, 10.2967/jnumed.112.113928
  40. Fagan A. M., Xiong C., Jasielec M. S., Bateman R. J., Goate A. M., Benzinger T. L. S., Ghetti B., Martins R. N., Masters C. L., Mayeux R., Ringman J. M., Rossor M. N., Salloway S., Schofield P. R., Sperling R. A., Marcus D., Cairns N. J., Buckles V. D., Ladenson J. H., Morris J. C., Holtzman D. M., , Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease, 10.1126/scitranslmed.3007901
  41. Maia L. F., Kaeser S. A., Reichwald J., Lambert M., Obermuller U., Schelle J., Odenthal J., Martus P., Staufenbiel M., Jucker M., Increased CSF A  during the very early phase of cerebral A  deposition in mouse models, 10.15252/emmm.201505026
  42. Dumurgier Julien, Paquet Claire, Benisty Sarah, Kiffel Claire, Lidy Claude, Mouton-Liger François, Chabriat Hugues, Laplanche Jean-Louis, Hugon Jacques, Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory, 10.1016/j.nbd.2010.07.007
  43. Marquié Marta, Normandin Marc D., Vanderburg Charles R., Costantino Isabel M., Bien Elizabeth A., Rycyna Lisa G., Klunk William E., Mathis Chester A., Ikonomovic Milos D., Debnath Manik L., Vasdev Neil, Dickerson Bradford C., Gomperts Stephen N., Growdon John H., Johnson Keith A., Frosch Matthew P., Hyman Bradley T., Gómez-Isla Teresa, Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue : Validation of PET Tracer, 10.1002/ana.24517
  44. Chhatwal Jasmeer P., Schultz Aaron P., Marshall Gad A., Boot Brendon, Gomez-Isla Teresa, Dumurgier Julien, LaPoint Molly, Scherzer Clemens, Roe Allyson D., Hyman Bradley T., Sperling Reisa A., Johnson Keith A., Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly, 10.1212/wnl.0000000000003050